InvestorsHub Logo
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Re: BioNewton post# 33478

Monday, 03/30/2015 11:24:10 AM

Monday, March 30, 2015 11:24:10 AM

Post# of 144820
"These landmark preclinical trials for abdominal cancers using the Company's platform technology were designed, in part, by the leading authority on pancreatic cancer, Dr. Daniel Von Hoff, and conducted by America's leading Contract Research Organization that specializes in preclinical and early-mid phase clinical trials in oncology. Having such distinguished authorities associated with these trials affirms the potential value and efficacy of the Company's technology and could result in future, fast-tracked clinical trials."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News